FDA Inspection 1086604 — Bracco Suisse SA
The FDA completed an inspection of Bracco Suisse SA on Nov 27, 2018 in Plan-les-Ouates. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 27, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Plan-les-Ouates (Switzerland)